<DOC>
	<DOCNO>NCT00727220</DOCNO>
	<brief_summary>The purpose study examine glycemic neuropsychological outcome young child Type I diabetes start insulin pump compare outcomes child utilize insulin pump . We propose assess 40 child IDDM 5 year age . 10 patient examine use multiple daily injection basal glargine , 10 use NPH Lente rapid-acting insulin , 20 examine prior 12 month implementation insulin pump therapy . These subject recruit follow currently undergo treatment Type 1 diabetes . Children recruit base upon insulin regimen primary diabetes physician chosen utilize clinically . Insulin regimens change study team . Outcome measure examine : glycemic outcome ( overall control , blood sugar variability ) , cognitive outcome , parent Stress , change diet .</brief_summary>
	<brief_title>Prospective Study Impact Insulin Pump Therapy Young Children With Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>1 . Children Type I diabetes : 24 insulin pump therapy recommend primary diabetes caretaker . 13 use NPH Lente insulin plus rapid acting insulin 13 use glargine insulin 2 . Children must 5 year age less time entry study . 3 . Children must diagnosis type I diabetes least 1 year time entry . 4 . Children must receive two insulin injection daily . 5 . In order test , child must moderate severe hypoglycemia ( blood glucose &lt; 60 mg/dl ) 24 hour precede test document home glucose test . 1 . Children exclude additional medical problem require treatment agent know affect blood glucose steroid Lasparaginase . 2 . Children must chronic illness addition diabetes .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>type 1 diabetes</keyword>
	<keyword>continuous glucose sensor monitoring</keyword>
</DOC>